Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Total Non-Current Liabilities (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Total Non-Current Liabilities for 3 consecutive years, with $289.1 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 286.58% to $289.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $289.1 million through Dec 2025, up 286.58% year-over-year, with the annual reading at $289.1 million for FY2025, 286.58% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $289.1 million at Nuvation Bio, up from $273.9 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $289.1 million in Q4 2025, with the low at $15.3 million in Q1 2023.
  • Average Total Non-Current Liabilities over 3 years is $99.4 million, with a median of $64.6 million recorded in 2024.
  • Peak annual rise in Total Non-Current Liabilities hit 367.14% in 2024, while the deepest fall reached 13.04% in 2024.
  • Over 3 years, Total Non-Current Liabilities stood at $16.0 million in 2023, then soared by 367.14% to $74.8 million in 2024, then surged by 286.58% to $289.1 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $289.1 million, $273.9 million, and $272.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.